cfDNA methylome profiling for detection and subtyping of small cell lung cancers DOI: 10.1038/s43018-022-00415-9 Bioinformatics & Biostatistics Nucleic Acids Biomarkers Preclinical Pharmacology
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary DOI: 10.1038/s41467-024-47195-7 Bioinformatics & Biostatistics Nucleic Acids Biomarkers
The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection DOI: 10.1186/s13059-023-03074-w Nucleic Acids Biomarkers
Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies DOI: 10.1016/j.molmed.2024.04.005 Nucleic Acids Biomarkers
Cell-free and extrachromosomal DNA profiling of small cell lung cancer DOI: 10.1016/j.molmed.2024.08.004 Nucleic Acids Biomarkers Preclinical Pharmacology
Comparison of cell-free and small extracellular-vesicle-associated DNA by sequencing plasma of lung cancer patients DOI: 10.1016/j.isci.2024.110742 Nucleic Acids Biomarkers
Mining nucleic acid “omics” to boost liquid biopsy in cancer DOI: 10.1016/j.xcrm.2024.101736 Bioinformatics & Biostatistics Nucleic Acids Biomarkers
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling DOI: 10.1101/gr.279144.124 Nucleic Acids Biomarkers
The effects of bioinformatics preprocessing on cell-free DNA fragment analysis DOI: 10.1093/gigascience/giaf139 Nucleic Acids Biomarkers
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium DOI: 10.1093/neuonc/noaf140 Nucleic Acids Biomarkers
